• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Gamma-glutamylaminecyclotransferase (A2LD1)

ACP10732

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP10732 Target NameGGACT
Target SynonymsGGACT; A2LD1; Gamma-glutamylaminecyclotransferase; GGACT; EC 4.3.2.8; AIG2-like domain-containing protein 1; Gamma-glutamylamine cyclotransferaseFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-153
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9BVM4
Background Information
  • Uniprot Id

    Q9BVM4

  • Target Species

    Human

  • Target Name

    GGACT

  • Target Full Name

    Gamma-glutamylaminecyclotransferase

  • Target Function

    Contributes to degradation of proteins cross-linked by transglutaminases by degrading the cross-link between a lysine and a glutamic acid residue. Catalyzes the formation of 5-oxo-L-proline from L-gamma-glutamyl-L-epsilon-lysine. Inactive with L-gamma-glutamyl-alpha-amino acid substrates such as L-gamma-glutamyl-L-alpha-cysteine and L-gamma-glutamyl-L-alpha-alanine.

  • Target Protein Families

    Gamma-glutamylcyclotransferase family

  • Target Synonyms

    GGACT; A2LD1; Gamma-glutamylaminecyclotransferase; GGACT; EC 4.3.2.8; AIG2-like domain-containing protein 1; Gamma-glutamylamine cyclotransferase

Inquire Recombinant Human Gamma-glutamylaminecyclotransferase (A2LD1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification